第13届圣地亚哥生物医药年会 － 6月21日# Biology - 生物学
S*A
1 楼
13th San Diego Bio-Pharma Conference 2014
Date: June 21st, 2014, 8:00am -5:00pm Location:
Hilton, San Diego/Del Mar Website: http://www.sabpa.org/html
Registration: https://www.123signup.com/register?id=dhdhz
$30 for early birds (by June 11th), $50 before end of June 18th, $80 for
onsite registration, students and postdocs $10 off (The fees include parking
at the hotel, program brochure, continental breakfast, coffee break, and
lunch).
Online registration closes after June 18th.
Organizer Sino-American Biomedical & Pharmaceutical
Professionals Association (SABPA)
Co-organizer BayHelix, SDCAA (San Diego Chinese American Association
), ACS-SD (American Chemical Society-San Diego), UCSD
Bio-Pharma Conference, SABPA’s annual flagship event is fast approaching.
With the recent new waves of IPOs, mergers & acquisitions, and new drug
approvals, this year we will showcase many San Diego biopharma companies and
research institutes that are pushing the boundaries with new breakthroughs
in therapeutics ranging from small molecules, to proteins to nucleic acids
and somewhere in between. You will hear many success stories from notable
companies such as Aragon. This conference will also bring together many
business leaders from around the globe with renewed enthusiasm of investing
in San Diego biotechnology industry to share their insights on industry
trends. The program is guaranteed to generate sizzling discussions and
stimulate new ideas.
Program
8:00 am Exhibition (all day)
8:00 am Continental Breakfast & Registration
8:45 am Welcome
9:00 am Keynote Speaker:
David Kabakoff, Ph.D., Executive Partner, Sofinnova Ventures
9:40 am Session I
Alan Lewis, Ph.D., CEO, Medistem
Dale Boger, Ph.D., Chair, Department of Chemistry, the Scripps Research
Institute
10:40 am Coffee Break
11:00 am Session II Panel Discussion: The Renaissance of San Diego
Biopharmaceutical Industry
Moderator: Timothy Hoctor, B.S., Vice President,
Professional Services, Elsevier Life Science Solutions
Chrysa Mineo, B.S., M.B.A., SVP, Receptos
Mike Grey, B.S., President and CEO, Lumena
Pharmaceuticals, Inc.; Venture Partner, Pappas Ventures
Henry Ji, Ph.D., co-founder, CEO, Sorrento Therapeutics
, Inc
Xiaobo Wang, Ph.D., Vice President, Chief Technology
Officer, ACEA Biosciences
12:00 pm Luncheon
1:30 pm San Diego Bio-Pharma Achievement Award
Award Recipient: Richard Heyman, Ph.D., President
and CEO, Seragon Pharmaceuticals
2:10 pm Session III
Alan Paau, CLP, MBA, Ph.D., Executive Director &
Vice Provost,Tech. Transfer & Economic Development, Cornell University
Jonathan Wang, Ph.D., Asia Senior Managing Partner, OrbiMed
3:10 pm Coffee Break
3:30 pm Session IV Panel Discussion: Innovation and Business
Transactions on A Global Scale (organized by BayHelix)
Moderator: Wei-Wei Zhang, M.D., Ph.D., Managing Director
, Adventin, Inc.
Greg Scott, Chairman, ChinaBio® Group
Jun Ren, Ph.D., CEO, NewSummit Group
Xianping Lu, Ph.D., Chairman, CEO and CSO, Shenzhen
Chipscreen Biosciences
Yajun Guo, M.D., Ph.D., Director, National Engineering Center
for Antibody Medicine; Director, State Key Laboratory of
Antibody Medicine and Targeting Therapy
Zhi Yang, Ph.D., Managing Partner, BioVeda China Fund
4:30 pm Session V Presentation from Wuhan Biolake
Junjie Yang, M.D., Ph.D., Chairman and CTO, Wuhan Optic
Valley Bridgebio Bio-technology Ltd
5:00 pm Closing and iPad-mini raffle
Date: June 21st, 2014, 8:00am -5:00pm Location:
Hilton, San Diego/Del Mar Website: http://www.sabpa.org/html
Registration: https://www.123signup.com/register?id=dhdhz
$30 for early birds (by June 11th), $50 before end of June 18th, $80 for
onsite registration, students and postdocs $10 off (The fees include parking
at the hotel, program brochure, continental breakfast, coffee break, and
lunch).
Online registration closes after June 18th.
Organizer Sino-American Biomedical & Pharmaceutical
Professionals Association (SABPA)
Co-organizer BayHelix, SDCAA (San Diego Chinese American Association
), ACS-SD (American Chemical Society-San Diego), UCSD
Bio-Pharma Conference, SABPA’s annual flagship event is fast approaching.
With the recent new waves of IPOs, mergers & acquisitions, and new drug
approvals, this year we will showcase many San Diego biopharma companies and
research institutes that are pushing the boundaries with new breakthroughs
in therapeutics ranging from small molecules, to proteins to nucleic acids
and somewhere in between. You will hear many success stories from notable
companies such as Aragon. This conference will also bring together many
business leaders from around the globe with renewed enthusiasm of investing
in San Diego biotechnology industry to share their insights on industry
trends. The program is guaranteed to generate sizzling discussions and
stimulate new ideas.
Program
8:00 am Exhibition (all day)
8:00 am Continental Breakfast & Registration
8:45 am Welcome
9:00 am Keynote Speaker:
David Kabakoff, Ph.D., Executive Partner, Sofinnova Ventures
9:40 am Session I
Alan Lewis, Ph.D., CEO, Medistem
Dale Boger, Ph.D., Chair, Department of Chemistry, the Scripps Research
Institute
10:40 am Coffee Break
11:00 am Session II Panel Discussion: The Renaissance of San Diego
Biopharmaceutical Industry
Moderator: Timothy Hoctor, B.S., Vice President,
Professional Services, Elsevier Life Science Solutions
Chrysa Mineo, B.S., M.B.A., SVP, Receptos
Mike Grey, B.S., President and CEO, Lumena
Pharmaceuticals, Inc.; Venture Partner, Pappas Ventures
Henry Ji, Ph.D., co-founder, CEO, Sorrento Therapeutics
, Inc
Xiaobo Wang, Ph.D., Vice President, Chief Technology
Officer, ACEA Biosciences
12:00 pm Luncheon
1:30 pm San Diego Bio-Pharma Achievement Award
Award Recipient: Richard Heyman, Ph.D., President
and CEO, Seragon Pharmaceuticals
2:10 pm Session III
Alan Paau, CLP, MBA, Ph.D., Executive Director &
Vice Provost,Tech. Transfer & Economic Development, Cornell University
Jonathan Wang, Ph.D., Asia Senior Managing Partner, OrbiMed
3:10 pm Coffee Break
3:30 pm Session IV Panel Discussion: Innovation and Business
Transactions on A Global Scale (organized by BayHelix)
Moderator: Wei-Wei Zhang, M.D., Ph.D., Managing Director
, Adventin, Inc.
Greg Scott, Chairman, ChinaBio® Group
Jun Ren, Ph.D., CEO, NewSummit Group
Xianping Lu, Ph.D., Chairman, CEO and CSO, Shenzhen
Chipscreen Biosciences
Yajun Guo, M.D., Ph.D., Director, National Engineering Center
for Antibody Medicine; Director, State Key Laboratory of
Antibody Medicine and Targeting Therapy
Zhi Yang, Ph.D., Managing Partner, BioVeda China Fund
4:30 pm Session V Presentation from Wuhan Biolake
Junjie Yang, M.D., Ph.D., Chairman and CTO, Wuhan Optic
Valley Bridgebio Bio-technology Ltd
5:00 pm Closing and iPad-mini raffle